iRhythm (IRTC) Stock Sees Modest Fair Value Cut After VitalConnect And Zio MCT Questions
Is iRhythm Holdings (IRTC) Undervalued After Its Share Price Pullback?
iRhythm Holdings (IRTC) Stock May Be A Bargain After Data Breach Probe
Piper Sandler Initiates Coverage On iRhythm Holdings with Overweight Rating, Announces Price Target of $160
iRhythm Holdings to Report Third Quarter 2026 Financial Results on November 5, 2026
iRhythm Holdings (IRTC) Disclosed Unauthorized Access To Patient Data
Wells Fargo Maintains Overweight on iRhythm Holdings, Lowers Price Target to $150
iRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care
Needham Maintains Buy on iRhythm Holdings, Raises Price Target to $194
iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026
iRhythm Holdings Issues Update On Cybersecurity Incident Previously Disclosed in June 2026; Continues To Believe Incident Not Expected To Have Material Impact On Co's Financial Condition
Firing on All Cylinders: iRhythm (NASDAQ:IRTC) Q2 Earnings Lead the Way
iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference
iRhythm Holdings (IRTC) Faces An Audit Committee Shift As Its Undervalued Narrative Holds
iRhythm: The Algorithmic Margin Inflection Changes The Story
2 Reasons to Like IRTC (and 1 Not So Much)
Wells Fargo Maintains Overweight on iRhythm Holdings, Lowers Price Target to $168
The Top 5 Analyst Questions From iRhythm’s Q2 Earnings Call
iRhythm (IRTC) Q2 2026 Earnings Call Transcript
Why iRhythm (IRTC) Stock Is Trading Up Today
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.